Evelo Biosciences, Inc. (EVLO) Social Stream
EVELO BIOSCIENCES INC (EVLO) Price Targets From Analysts
Use the tables below to see what analysts covering EVELO BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 6 | $41.5 | $9 | $20.9 | $0.129 | 16101.55% |
| 2022-01-31 | 6 | $41.5 | $6 | $20.3 | $0.129 | 15636.43% |
| 2022-04-11 | 6 | $41.5 | $6 | $19.1 | $0.129 | 14706.2% |
| 2022-08-12 | 6 | $41.5 | $6 | $15.9 | $0.129 | 12225.58% |
| 2022-08-15 | 6 | $41.5 | $5 | $14.5 | $0.129 | 11140.31% |
| 2022-08-24 | 6 | $41.5 | $5 | $14.3 | $0.129 | 10985.27% |
| 2022-09-09 | 6 | $13 | $4 | $7.25 | $0.129 | 5520.16% |
| 2022-11-16 | 5 | $13 | $4 | $6.875 | $0.129 | 5229.46% |
| 2022-11-21 | 5 | $13 | $2.5 | $6.25 | $0.129 | 4744.96% |
| 2023-02-02 | 5 | $5 | $0.3 | $2.95 | $0.129 | 2186.82% |
| 2023-02-15 | 5 | $5 | $0.3 | $2.45 | $0.129 | 1799.22% |
| 2023-03-16 | 5 | $5 | $0.1 | $2.4 | $0.129 | 1760.47% |
| 2023-05-17 | 5 | $2.5 | $0.1 | $1.4 | $0.129 | 985.27% |
The Trend in the Analyst Price Target
EVLO's average price target has moved down $10.27 over the prior 36 months.
Over the past 40 weeks, EVLO's average upside potential has been 446.06%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-12 | 6 | 41.5 | 6.0 | 15.900 | 2.740 | 480.29% |
| 2022-08-12 | 6 | 41.5 | 6.0 | 17.300 | 2.740 | 531.39% |
| 2022-11-16 | 5 | 13.0 | 4.0 | 6.875 | 2.290 | 200.22% |
| 2023-02-02 | 5 | 5.0 | 0.3 | 2.950 | 0.855 | 245.03% |
| 2023-03-17 | 5 | 2.5 | 0.1 | 1.400 | 0.259 | 440.54% |
EVLO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.8 | 1 | 0 | 3 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
EVLO's average broker recommendation rating worsened by 1.47 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EVLO as an investment opportunity.
- In terms of how EVELO BIOSCIENCES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1590.6% of that group.
- EVELO BIOSCIENCES INC's variance in analysts' estimates is lower than -1454.07% of all US stocks.
- EVLO has a greater average analyst price target than 305.9% of Healthcare stocks.
- In the context of stocks in the small market cap category, EVELO BIOSCIENCES INC's number of analysts covering the stock is greater than 1077.64% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to EVELO BIOSCIENCES INC are COGT, UBX, and FIXX.
View All Top Stocks by Price Target
Make investment decisions regarding EVLO using the data that counts. Try POWR Ratings for free.